Get a job referral to Adaptive Biotechnologies

Description

Adaptive Biotechnologies (NASDAQ: ADPT) is a leading biotechnology company founded in 2009. The company specializes in combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors. This innovative approach has revolutionized the field of immunology and enabled advancements in the diagnosis and treatment of various diseases, including cancer and autoimmune disorders. Adaptive Biotechnologies is at the forefront of personalized medicine, leveraging its technology to develop cutting-edge solutions that have the potential to transform healthcare on a global scale.